Epidemiology and staging of renal cell carcinoma

Seminars in Interventional Radiology

Volumn 31, Issue 1, 2014, Pages 3-8

  Ridge, Carole A ^a   Pua, Bradley B ^b   Madoff, David C ^b  

^a MATER MISERICORDIAE UNIVERSITY HOSPITAL   (Ireland)

^b NEW YORK PRESBYTERIAN HOSPITAL   (United States)

Author keywords

epidemiology and staging; incidence; kidney cancer; mortality; renal cell carcinoma; risk factors

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; CANCER THERAPY; COMORBIDITY; DEMOGRAPHY; EPIDEMIOLOGY; GENETIC RISK; HISTOLOGY; HUMAN; KIDNEY CARCINOMA; RISK FACTOR; SMOKING; STAGING;

EID: 84896708338     PISSN: 07399529     EISSN: 10988963     Source Type: Journal    
DOI: 10.1055/s-0033-1363837     Document Type: Article

References (33)

1. Ferlay J., Shin H. R., Bray F., Forman D., Mathers C., Parkin D. M. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer: 2010; 127 12 2893 2917
2. Ljungberg B., Campbell S. C., Choi H. Y., et al. The epidemiology of renal cell carcinoma. Eur Urol: 2011; 60 4 615 621
3. Howlader N., Noone A. M., Krapcho M., et al, (eds). SEER Cancer Statistics Review, 1975-2010, National Cancer Institute. Bethesda, MD, http://seer.cancer.gov/csr/1975-2010/, based on November 2012 SEER data submission, posted to the SEER web site, April 2013
4. Levi F., Ferlay J., Galeone C., et al. The changing pattern of kidney cancer incidence and mortality in Europe. BJU Int: 2008; 101 8 949 958
5. Chow W. H., Linehan W. M., Devesa S. S. Re: Rising incidence of small renal masses: a need to reassess treatment effect. J Natl Cancer Inst: 2007; 99 7 569 570, author reply 570-571
6. Chow W. H., Devesa S. S. Contemporary epidemiology of renal cell cancer. Cancer J: 2008; 14 5 288 301
7. Berndt S. I., Carter H. B., Schoenberg M. P., Newschaffer C. J. Disparities in treatment and outcome for renal cell cancer among older black and white patients. J Clin Oncol: 2007; 25 24 3589 3595
8. Becker A., Roghmann F., Trinh Q. D., et al. Sociodemographic disparities in the treatment of small renal masses. BJU Int: 2013; 111 8 E274 E282
9. Rampersaud E. N., Klatte T., Bass G., et al. The effect of gender and age on kidney cancer survival: younger age is an independent prognostic factor in women with renal cell carcinoma. Urol Oncol: 2014; 32 1 30
10. Chow W. H., Dong L. M., Devesa S. S. Epidemiology and risk factors for kidney cancer. Nat Rev Urol: 2010; 7 5 245 257
11. Tsivian M., Moreira D. M., Caso J. R., Mouraviev V., Polascik T. J. Cigarette smoking is associated with advanced renal cell carcinoma. J Clin Oncol: 2011; 29 15 2027 2031
12. Orth S. R. Cigarette smoking: an important renal risk factor-far beyond carcinogenesis. Tob Induc Dis: 2002; 1 2 137 155
13. Clague J., Shao L., Lin J., et al. Sensitivity to NNKOAc is associated with renal cancer risk. Carcinogenesis: 2009; 30 4 706 710
14. Zhu Y., Horikawa Y., Yang H., Wood C. G., Habuchi T., Wu X. BPDE induced lymphocytic chromosome 3p deletions may predict renal cell carcinoma risk. J Urol: 2008; 179 6 2416 2421
15. Macleod L. C., Hotaling J. M., Wright J. L., et al. Risk Factors for Renal Cell Carcinoma in the Vitamin and Lifestyle (VITAL) Study. J Urol: 2013; 190 5 1657 1661
16. Häggström C., Rapp K., Stocks T., et al. Metabolic factors associated with risk of renal cell carcinoma. PLoS ONE: 2013; 8 2 e57475
17. Colt J. S., Schwartz K., Graubard B. I., et al. Hypertension and risk of renal cell carcinoma among white and black Americans. Epidemiology: 2011; 22 6 797 804
18. Chauveau D., Duvic C., Chrétien Y., et al. Renal involvement in von Hippel-Lindau disease. Kidney Int: 1996; 50 3 944 951
19. Pfaffenroth E. C., Linehan W. M. Genetic basis for kidney cancer: opportunity for disease-specific approaches to therapy. Expert Opin Biol Ther: 2008; 8 6 779 790
20. Tomlinson I. P., Alam N. A., Rowan A. J., et al. Multiple Leiomyoma Consortium. Germline mutations in FH predispose to dominantly inherited uterine fibroids, skin leiomyomata and papillary renal cell cancer. Nat Genet: 2002; 30 4 406 410
21. Northrup B. E., Jokerst C. E., Grubb R. L. III, Menias C. O., Khanna G., Siegel C. L. Hereditary renal tumor syndromes: imaging findings and management strategies. AJR Am J Roentgenol: 2012; 199 6 1294 1304
22. Cohen D., Zhou M. Molecular genetics of familial renal cell carcinoma syndromes. Clin Lab Med: 2005; 25 2 259 277
23. Sheth S., Scatarige J. C., Horton K. M., Corl F. M., Fishman E. K. Current concepts in the diagnosis and management of renal cell carcinoma: role of multidetector CT and three-dimensional CT. Radiographics: 2001; 21 (Spec No): S237 S254
24. Edge S. B., Byrd D. R., Compton C. C., Fritz A. G., Greene F. L., Trotti A. AJCC Cancer Staging Manual. 7th ed. New York, NY Springer Science and Business Media: 2010
25. Cho M. C., Kim J. K., Moon K. C., Kim H. H., Kwak C. Prognostic factor for Korean patients with renal cell carcinoma and venous tumor thrombus extension: application of the new 2009 TNM staging system. Int Braz J Urol: 2013; 39 3 353 363
26. Ljungberg B., Cowan N. C., Hanbury D. C., et al. European Association of Urology Guideline Group. EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol: 2010; 58 3 398 406
27. Eble J. N., Sauter G., Epstein J. I., Sesterhenn I. A. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. World Health Organization Classification of Tumours. Lyon, France IARC Press: 2004; 7
28. Pignot G., Elie C., Conquy S., et al. Survival analysis of 130 patients with papillary renal cell carcinoma: prognostic utility of type 1 and type 2 subclassification. Urology: 2007; 69 2 230 235
29. Fuhrman S. A., Lasky L. C., Limas C. Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol: 1982; 6 7 655 663
30. Kontak J. A., Campbell S. C. Prognostic factors in renal cell carcinoma. Urol Clin North Am: 2003; 30 3 467 480
31. Meskawi M., Sun M., Trinh Q. D., et al. A review of integrated staging systems for renal cell carcinoma. Eur Urol: 2012; 62 2 303 314
32. Zisman A., Pantuck A. J., Dorey F., et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol: 2001; 19 6 1649 1657
33. Zisman A., Pantuck A. J., Wieder J., et al. Risk group assessment and clinical outcome algorithm to predict the natural history of patients with surgically resected renal cell carcinoma. J Clin Oncol: 2002; 20 23 4559 4566